“Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients”

por Pappas, Dimitrios A, Kremer, Joel M, Reed, George, Greenberg, Jeffrey D, Curtis, Jeffrey R
Publicado 2014

Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry

por Mease, Philip J., van der Heijde, Désirée, Karki, Chitra, Liu, Mei, Park, Yujin, Greenberg, Jeffrey D.
Publicado 2018

Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries

por Mease, Philip J., Liu, Mei, Rebello, Sabrina, Kang, Hyungjoo, Yi, Esther, Park, Yujin, Greenberg, Jeffrey D.
Publicado 2019

Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registry

por Mease, Philip J, Collier, David H, Saunders, Katherine C, Li, Guo, Kremer, Joel M, Greenberg, Jeffrey D
Publicado 2015

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

por Kavanaugh, Arthur, Singh, Rakesh, Karki, Chitra, Etzel, Carol J., Kremer, Joel M., Greenberg, Jeffrey D., Griffith, Jenny
Publicado 2018

Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study

por Kennish, Lauren, Attur, Mukundan, Oh, Cheongeun, Krasnokutsky, Svetlana, Samuels, Jonathan, Greenberg, Jeffrey D, Huang, Xi, Abramson, Steven B
Publicado 2014

Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necro...

por Harrold, Leslie R., Reed, George W., Magner, Robert, Shewade, Ashwini, John, Ani, Greenberg, Jeffrey D., Kremer, Joel M.
Publicado 2015

Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population

por Pappas, Dimitrios A., Reed, George W., Saunders, Katherine, John, Ani, Shewade, Ashwini, Greenberg, Jeffrey D., Kremer, Joel M.
Publicado 2015

Delays in Initiation of Disease-Modifying Therapy in Rheumatoid Arthritis Patients: Data from a US-Based Registry

por Pappas, Dimitrios A., Kent, Jeffrey D., Greenberg, Jeffrey D., Mason, Marc A., Kremer, Joel M., Holt, Robert J.
Publicado 2015

Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation

por Ljung, Lotta, Ueda, Peter, Liao, Katherine P, Greenberg, Jeffrey D, Etzel, Carol J, Solomon, Daniel H, Askling, Johan
Publicado 2018

Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study fro...

por Mease, Philip J, Karki, Chitra, Liu, Mei, Li, YouFu, Gershenson, Bernice, Feng, Hua, Hur, Peter, Greenberg, Jeffrey D
Publicado 2019

Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry

por Harrold, Leslie R., Reed, George W., Karki, Chitra, Magner, Robert, Shewade, Ashwini, John, Ani, Kremer, Joel M., Greenberg, Jeffrey D.
Publicado 2016

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry

por Harrold, Leslie R., Reed, George W., Solomon, Daniel H., Curtis, Jeffrey R., Liu, Mei, Greenberg, Jeffrey D., Kremer, Joel M.
Publicado 2016

Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry

por Harrold, Leslie R., John, Ani, Best, Jennie, Zlotnick, Steve, Karki, Chitra, Li, YouFu, Greenberg, Jeffrey D., Kremer, Joel M.
Publicado 2017

Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Reg...

por Mease, Philip J, Karki, Chitra, Liu, Mei, Kavanaugh, Arthur, Ritchlin, Christopher T, Huynh, Doquyen Hoa, Palmer, Jacqueline B, Greenberg, Jeffrey D
Publicado 2018

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor

por Harrold, Leslie R, Reed, George W, Kremer, Joel M, Curtis, Jeffrey R, Solomon, Daniel H, Hochberg, Marc C, Greenberg, Jeffrey D
Publicado 2015

Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US‐Based Corrona Registry

por Mease, Philip J., Heijde, Désirée Van Der, Karki, Chitra, Palmer, Jacqueline B., Liu, Mei, Pandurengan, Renganayaki, Park, Yujin, Greenberg, Jeffrey D.
Publicado 2018

Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psorias...

por Strober, Bruce, Greenberg, Jeffrey D, Karki, Chitra, Mason, Marc, Guo, Ning, Hur, Peter, Zhao, Yang, Herrera, Vivian, Lin, Feng, Lebwohl, Mark
Publicado 2019

Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predi...

por Kay, Jonathan, Morgacheva, Olga, Messing, Susan P, Kremer, Joel M, Greenberg, Jeffrey D, Reed, George W, Gravallese, Ellen M, Furst, Daniel E
Publicado 2014

Malignancy validation in a United States registry of rheumatoid arthritis patients

por Fisher, Mark C, Furer, Victoria, Hochberg, Marc C, Greenberg, Jeffrey D, Kremer, Joel M, Curtis, Jeff R, Reed, George, Harrold, Leslie, Solomon, Daniel H
Publicado 2012